Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue, White | 4 | 2026 | 93 | 1.560 |
Why?
|
| Energy Metabolism | 3 | 2026 | 400 | 1.370 |
Why?
|
| PPAR alpha | 2 | 2021 | 33 | 1.240 |
Why?
|
| Adipokines | 2 | 2026 | 37 | 1.130 |
Why?
|
| Thermogenesis | 6 | 2026 | 128 | 1.080 |
Why?
|
| Adipose Tissue, Brown | 4 | 2026 | 126 | 0.960 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2026 | 216 | 0.890 |
Why?
|
| Glucose | 2 | 2026 | 478 | 0.800 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2022 | 35 | 0.710 |
Why?
|
| Cardiovascular Diseases | 2 | 2026 | 872 | 0.690 |
Why?
|
| Organelle Biogenesis | 2 | 2018 | 21 | 0.680 |
Why?
|
| Zinc Fingers | 1 | 2021 | 105 | 0.680 |
Why?
|
| Adipose Tissue | 1 | 2021 | 301 | 0.580 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2026 | 733 | 0.570 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2018 | 36 | 0.550 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 277 | 0.460 |
Why?
|
| Neoplasms | 2 | 2023 | 1376 | 0.450 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 1226 | 0.430 |
Why?
|
| Mitochondria | 1 | 2018 | 413 | 0.420 |
Why?
|
| Liver | 1 | 2018 | 874 | 0.390 |
Why?
|
| Transcription Factors | 3 | 2018 | 1559 | 0.390 |
Why?
|
| Mice | 12 | 2026 | 11172 | 0.370 |
Why?
|
| Animals | 14 | 2026 | 21450 | 0.300 |
Why?
|
| Cytochrome P450 Family 4 | 1 | 2026 | 5 | 0.240 |
Why?
|
| Diet, High-Fat | 2 | 2018 | 181 | 0.240 |
Why?
|
| Ubiquitins | 1 | 2026 | 42 | 0.240 |
Why?
|
| Mice, Knockout | 3 | 2021 | 2168 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 3500 | 0.230 |
Why?
|
| Taste | 1 | 2026 | 41 | 0.230 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2026 | 139 | 0.220 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2026 | 92 | 0.220 |
Why?
|
| Biocompatible Materials | 1 | 2026 | 154 | 0.210 |
Why?
|
| Karyopherins | 1 | 2024 | 10 | 0.210 |
Why?
|
| Deoxyribonucleotides | 1 | 2024 | 13 | 0.210 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2024 | 39 | 0.210 |
Why?
|
| Liposomes | 1 | 2024 | 117 | 0.200 |
Why?
|
| Recombinant Proteins | 1 | 2026 | 709 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 151 | 0.200 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1633 | 0.190 |
Why?
|
| Gene Editing | 2 | 2024 | 331 | 0.190 |
Why?
|
| Metabolic Diseases | 1 | 2023 | 59 | 0.190 |
Why?
|
| Signal Transduction | 2 | 2026 | 3162 | 0.180 |
Why?
|
| Insulin | 1 | 2026 | 696 | 0.180 |
Why?
|
| Cytokines | 1 | 2026 | 964 | 0.180 |
Why?
|
| Methylation | 1 | 2022 | 130 | 0.180 |
Why?
|
| Adipocytes, Brown | 2 | 2022 | 46 | 0.180 |
Why?
|
| Cell Line, Tumor | 2 | 2026 | 1573 | 0.180 |
Why?
|
| Arginine | 1 | 2022 | 136 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2026 | 829 | 0.150 |
Why?
|
| Humans | 13 | 2026 | 65632 | 0.150 |
Why?
|
| Protamines | 1 | 2018 | 6 | 0.140 |
Why?
|
| Polycomb-Group Proteins | 1 | 2018 | 21 | 0.140 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2018 | 31 | 0.140 |
Why?
|
| Ligases | 1 | 2018 | 27 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2024 | 718 | 0.130 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2017 | 6 | 0.130 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2017 | 29 | 0.130 |
Why?
|
| Cellular Reprogramming | 1 | 2017 | 41 | 0.130 |
Why?
|
| Breast Neoplasms | 1 | 2026 | 1233 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 768 | 0.130 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 50 | 0.130 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 90 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2017 | 115 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2017 | 224 | 0.120 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 19 | 0.120 |
Why?
|
| Male | 5 | 2026 | 31281 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 404 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 441 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2319 | 0.100 |
Why?
|
| Hyaluronic Acid | 2 | 2003 | 70 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 663 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2026 | 124 | 0.060 |
Why?
|
| Moloney murine leukemia virus | 1 | 2024 | 17 | 0.050 |
Why?
|
| Thyroid Hormones | 1 | 2024 | 81 | 0.050 |
Why?
|
| Mesoderm | 1 | 2003 | 89 | 0.050 |
Why?
|
| Adrenergic Agents | 1 | 2022 | 15 | 0.050 |
Why?
|
| Glioma | 1 | 2003 | 101 | 0.050 |
Why?
|
| Research | 1 | 2023 | 195 | 0.040 |
Why?
|
| Disease Progression | 1 | 2026 | 1225 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2003 | 414 | 0.040 |
Why?
|
| Transfection | 2 | 2018 | 700 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2023 | 369 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2024 | 925 | 0.030 |
Why?
|
| Sumoylation | 1 | 2018 | 17 | 0.030 |
Why?
|
| Mutation | 1 | 2024 | 2670 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 617 | 0.030 |
Why?
|
| Uncoupling Protein 1 | 1 | 2015 | 51 | 0.030 |
Why?
|
| Point Mutation | 1 | 2015 | 168 | 0.030 |
Why?
|
| Ion Channels | 1 | 2015 | 92 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 152 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 109 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 207 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 181 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 1277 | 0.030 |
Why?
|
| Body Weight | 1 | 2015 | 377 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2189 | 0.020 |
Why?
|
| Adipocytes | 1 | 2015 | 275 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 689 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 2 | 2003 | 289 | 0.020 |
Why?
|
| Female | 2 | 2026 | 34294 | 0.020 |
Why?
|
| Hyaluronan Synthases | 1 | 2003 | 2 | 0.010 |
Why?
|
| Gelatinases | 1 | 2003 | 9 | 0.010 |
Why?
|
| Glucuronosyltransferase | 1 | 2003 | 9 | 0.010 |
Why?
|
| Keratins | 1 | 2003 | 31 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 77 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2003 | 34 | 0.010 |
Why?
|
| Laminin | 1 | 2003 | 81 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 202 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2003 | 167 | 0.010 |
Why?
|
| beta Catenin | 1 | 2003 | 100 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 132 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 218 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 2003 | 55 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2003 | 141 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 178 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 135 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 426 | 0.010 |
Why?
|
| Dogs | 1 | 2003 | 317 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2003 | 204 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 401 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 321 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 963 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 1235 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 2029 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1100 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 3776 | 0.010 |
Why?
|